TherapeuticsMD, Inc. (TXMD) has seen some recent movement in the market and its shares closed at $1.6000 yesterday. Traders are starting to take notice of TXMD as the shares traded as high as $1.6900 and as low as $1.6000 in the prior trading session.

TherapeuticsMD, Inc. (TXMD) average trading volume is 3.68M. However, in the prior trading session TherapeuticsMD, Inc. (TXMD) traded 1,307,120 shares. The 1st downside support level on TXMD is $1.56 and the 1st resistance level on TXMD is $2.29. TXMD fifty day moving average is $1.4829 and TXMD 200 day moving average is $1.3957.

TherapeuticsMD, Inc. (TXMD) most current performance has been indicated by the recent movement in TXMD shares. TXMD has performed 19.40% over the past 4 weeks, TXMD has performed -3.61% over the past quarter and TXMD has shown -59.13% over the past year. TherapeuticsMD, Inc. (TXMD) has a 52 week range of $0.8500 to $3.9000. TherapeuticsMD, Inc. (TXMD) is trading 87.57% from its 52 week low and -60.00% from its 52 week high. TherapeuticsMD, Inc. (TXMD) is displaying a 36.32% short float displaying the sum short in the float.

TXMD has 271.88M shares outstanding and 238.66M shares in the float. TherapeuticsMD, Inc. (TXMD) currently has a market cap of $464.67M and income of -190.20M. The EPS next quarter for TXMD is -0.14 and forecasted EPS next year is 53.10%. The market cap of TherapeuticsMD, Inc. (TXMD) at $464.67M signifies how many Traders own shares of TXMD and is based off the last price ($1.6000) of TXMD and the sum of shares outstanding (271.88M) with TherapeuticsMD, Inc. (TXMD).

TherapeuticsMD, Inc. (TXMD) has aggregate cash (mrq) of 113.84M, aggregate cash per share (mrq) of 0.42, aggregate debt of TXMD remains at 255.22M. TherapeuticsMD, Inc. (TXMD) running cash flow (ttm) is -172.12M, TXMD leveraged free cash flow (ttm) is -125.4M.

TXMD is trading 4.29% above (bullish) its SMA20, 4.02% above (bullish) its SMA50 and 0.63% above (bullish) its SMA200.